Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Breakthrough infections after COVID-19 vaccination: Insights, perspectives and challenges
Evropi Amanatidou, Anna Gkiouliava, Eva Pella, et al.
Metabolism Open (2022) Vol. 14, pp. 100180-100180
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Durability of Vaccine-Induced and Natural Immunity Against COVID-19: A Narrative Review
Nick Pooley, Salim S. Abdool Karim, Béhazine Combadière, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 2, pp. 367-387
Open Access | Times Cited: 63
Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges
Dimitrios Tsilingiris, Natalia G. Vallianou, Ιrene Karampela, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10458-10458
Open Access | Times Cited: 30
The Kidney in Obesity: Current Evidence, Perspectives and Controversies
Dimitris Kounatidis, Natalia G. Vallianou, Theodora Stratigou, et al.
Current Obesity Reports (2024) Vol. 13, Iss. 4, pp. 680-702
Closed Access | Times Cited: 7
Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
Michael DiIorio, Kevin Kennedy, Jean W. Liew, et al.
RMD Open (2022) Vol. 8, Iss. 2, pp. e002587-e002587
Open Access | Times Cited: 34
Long-term assessment of anti-SARS-CoV-2 antibody levels post-pandemic: Tracking the dynamics after two, three, and four COVID-19 vaccine doses
Fatemeh Ashrafian, ‪Mostafa Salehi-Vaziri, Ehsan Mostafavi, et al.
Journal of Infection and Public Health (2025) Vol. 18, Iss. 3, pp. 102676-102676
Open Access
Cracking the code of a correlate of protection against SARS-CoV-2 breakthrough infection in cancer patients
Yana Debie, Irene Garcia-Fogeda, Lander Willem, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Application and significance of SIRVB model in analyzing COVID-19 dynamics
Pavithra Ariyaratne, Lumbini P. Ramasinghe, Jonathan S. Ayyash, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Preclinical evaluation of safety and immunogenicity of a primary series intranasal COVID-19 vaccine candidate (BBV154) and humoral immunogenicity evaluation of a heterologous prime-boost strategy with COVAXIN (BBV152)
Raju Sunagar, Sai Prasad, Raches Ella, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
Recent progress in application of nanovaccines for enhancing mucosal immune responses
Guangsheng Du, Ming Qin, Xun Sun
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 6, pp. 2334-2345
Open Access | Times Cited: 18
Transcriptionally active nasopharyngeal commensals and opportunistic microbial dynamics define mild symptoms in the COVID 19 vaccination breakthroughs
Priti Devi, Pallawi Kumari, Aanchal Yadav, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 2, pp. e1011160-e1011160
Open Access | Times Cited: 11
Genomic surveillance of SARS-CoV-2 in COVID-19 vaccinated healthcare workers in Lebanon
Habib Alkalamouni, Farouk F. Abou Hassan, Mirna Bou Hamdan, et al.
BMC Medical Genomics (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 10
Antiviral activity of the host defense peptide piscidin 1: investigating a membrane-mediated mode of action
Tristan Bepler, Michael D. Barrera, Mary T. Rooney, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 3
Efficacy, Immunogenicity, and Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases: A Systematic Review and Meta-Analysis
Alvina Widhani, Anshari Saifuddin Hasibuan, Retia Rismawati, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1456-1456
Open Access | Times Cited: 8
Clinical metabolomics: useful insights, perspectives and challenges
Μaria Dalamaga
Metabolism Open (2024) Vol. 22, pp. 100290-100290
Open Access | Times Cited: 2
A Mixed-Methods Study of COVID-19 Vaccine Acceptance and Its Determinants Among Pregnant Women in Northeast Ethiopia
Zenebe Tefera, Mandefro Assefaw
Patient Preference and Adherence (2022) Vol. Volume 16, pp. 2287-2299
Open Access | Times Cited: 13
Emergence of SARS‐CoV‐2 Omicron variant and strategies for tackling the infection
Yan Wu, Yiyin Long, Feng Wang, et al.
Immunity Inflammation and Disease (2022) Vol. 10, Iss. 12
Open Access | Times Cited: 13
The Fourth Dose of mRNA COVID-19 Vaccine Following 12 Different Three-Dose Regimens: Safety and Immunogenicity to Omicron BA.4/BA.5
Sitthichai Kanokudom, Jira Chansaenroj, Nungruthai Suntronwong, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 570-570
Open Access | Times Cited: 6
Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights Into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges
Dimitrios Tsilingiris, Natalia G. Vallianou, Ιrene Karampela, et al.
(2023)
Open Access | Times Cited: 6
Association between breakthrough infection with COVID-19 and Toxoplasma gondii: a cross-sectional study
Marwa A. Gouda, Hind S. AboShabaan, Ahmed S. Abdelgawad, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Infection- or AZD1222 vaccine-mediated immunity reduces SARS-CoV-2 transmission but increases Omicron competitiveness in hamsters
Julia R. Port, Claude Kwe Yinda, Jade C. Riopelle, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 6
A Pictorial Essay Describing the CT Imaging Features of COVID-19 Cases throughout the Pandemic with a Special Focus on Lung Manifestations and Extrapulmonary Vascular Abdominal Complications
Barbara Brogna, Elio Bignardi, A. Megliola, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2113-2113
Open Access | Times Cited: 5
Clinical features of coronavirus disease 2019 in Korean pediatric patients: a single-center retrospective study
Ji Eun Jeong, Hai Lee Chung, Young Hwan Kim, et al.
Kosin Medical Journal (2024) Vol. 39, Iss. 2, pp. 99-111
Open Access | Times Cited: 1
SARS-CoV-2 Vaccines: The Mucosal Immunity Imperative
Eli Y. Adashi, Philip A. Gruppuso
Mayo Clinic Proceedings (2022) Vol. 97, Iss. 10, pp. 1771-1773
Open Access | Times Cited: 8
The fourth dose of mRNA COVID-19 vaccine following 12 different three-dose regimens: Safety and immunogenicity to Omicron BA.4/BA.5
Sitthichai Kanokudom, Jira Chansaenroj, Nungruthai Suntronwong, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Correlates of breakthrough Omicron (B.1.1.529) infections in a prospective cohort of vaccinated patients with rheumatic diseases
Libin Benny, Pankti Mehta, Sakir Ahmed, et al.
Rheumatology International (2023) Vol. 43, Iss. 6, pp. 1033-1039
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top